Danaher Reports Third Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/2/2026
- Nasdaq hits record high after softer jobs data tempers rate-hike bets
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- DataMeds AI's Corexa Pharmacy tops $1M in monthly revenue
- Equities rebound to close higher as surging Treasury yields recede
- Twilio, Vylor set to join S&P 500 as index reshuffles members
- onsemi cuts Synaptics deal price to $5.7B after rival bid
- Wells Fargo names 13 stocks as overweight tactical ideas
Danaher (DHR) PT Lowered to $277 at Baird
October 23, 2024 6:25 AM EDTBaird analyst Catherine Schulte lowered the price target on Danaher (NYSE: DHR) to $277.00 (from $278.00) while maintaining a Outperform rating.
The analyst comments "Maintain Outperform rating, new $277 price target (-$1). DHR reported 3Q results ahead of expectations, driven by Biotechnology and Cepheid respiratory upside.... More
Danaher (DHR) PT Lowered to $275 at Leerink Partners
October 23, 2024 6:05 AM EDTLeerink Partners analyst Puneet Souda lowered the price target on Danaher (NYSE: DHR) to $275.00 (from $280.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: We see DHR as the leader in the highly attractive, spec'd-in and recurring rev market of bioprocess tools,... More
